Call for projects 2024 – Immunology and pediatric cancers – Calls for projects

Results

List of results, mentioning the title of the project, the name of the project leader and the organization to which it belongs.

ZAP70 in Pediatric Liver Oncogenesis, Immunosuppression, and Immunotherapy Resistance

• Aksam WOMAN
• University of BORDEAUX

Innovative Therapies for SMARCB1-Deficient Cancers: Immune Profiling and Preclinical Development

• Eliane PIAGGIO
• Curie Institute

Towards the optimization and identification of new immunotherapy targets in T-ALL

• Unit TRADEMAN
• Faculty of Medicine-University Paris-Sud 11 / CNRS UMR 8253 – INSERM U1151

Spatio-temporal characterization of the macrophage-fibroblast-tumor cell dialogue in rhabdomyosarcomas: role in metastatic dissemination

• Ana HENNINO
• Inserm / INSERM 1052 – Center Léon Bérard

Evaluation committee

Composition of the evaluation committee – My PDF 71,31

Call for projects

The “Immunology and pediatric cancers” call for projects is open to all disciplines, without exception, and aims to support particularly innovative projects in pediatric immuno-oncology. The projects submitted may be fundamental or translational research projects. Each project can be carried out by a single or several teams, if collaboration is necessary. Teams usually carrying out research in the field of adult immuno-oncology are strongly invited to apply for this call for projects.

The proposed projects could, for example (non-exhaustive list), focus on:

• analysis of the influence of the immune system on the development of tumors (e.g. relationships between tumor types and level of maturity of immunity);
• the study of tumor-microenvironment interactions (understanding how tumor cells interact with non-malignant cells in the microenvironment and dissecting the mechanisms of interactions between tumors and immune cells);
• the study of tumor immunogenicity and response or resistance to treatments;
• the search and identification of new immunotherapeutic targets;
• the development of very innovative immunotherapy approaches (proof of concept stage);
• analysis of the evolution of the immune system as a function of age and the differences between the immune systems of children affected by cancer compared to unaffected children;
• etc.

Calendar

• The deadline for submission of applications is September 11, 2024 – 4:00 p.m.
• Access to submission from July 8, 2024

Documents

Log in to the PROJECTS Portal